Bain Capital Life Sciences key facts
- Bain Capital Life Sciences is a venture capital firm based in Boston, Massachusetts with 17 tracked portfolio companies.
- Notable positions include Freenome, Imperative Care, HeartFlow (NAS: HTFL).
- Bain Capital Life Sciences has 4 funds on record.
- The team roster lists 30 people.
- Bain Capital Life Sciences reports $66.7B in regulatory assets under management across 36 private funds, per its SEC Form ADV (2026-03).
About Bain Capital Life Sciences
Founded in 2016, Bain Capital Life Sciences is the corporate venture capital arm of Bain Capital, based in Boston, Massachusetts. The firm seeks to invest in companies operating in the pharmaceutical, biotechnology, medical device, diagnostic, and life science sectors.
Investment focus
Its SEC Form ADV lists $66.7 billion in regulatory assets under management across 36 private funds (Mar 2026).
Bain Capital Life Sciences portfolio at a glance
17 portfolio companies are on record for Bain Capital Life Sciences, including Freenome, Imperative Care and HeartFlow (NAS: HTFL). The book leans Drug Discovery (4), Decision/Risk Analysis (2) and Biotech (1).
15 of the 17 carry a recorded valuation.
Bain Capital Life Sciences funds
4 funds are on record for Bain Capital Life Sciences. The most recent is Bain Capital Life Sciences Fund IV, L.P. (2024 vintage).
Bain Capital Life Sciences team
30 people are on record at Bain Capital Life Sciences: 6 associates, 6 managing partners, 5 partners, 5 principals and 8 others. Senior names include Allyson Rinderle (Managing Director), Lei Meng (Managing Director) and Matthew Calistri (Managing Director). 30 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Bain Capital Life Sciences at the SEC
Form ADV · 2026-03 · CRD 145653- Regulatory AUM
- $66.7B
- Private fund assets
- $99.5B
- Private funds
- 36 · 36 private equity
- Staff
- 919
- Registered office
- BOSTON, MA
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as BAIN CAPITAL PRIVATE EQUITY, LP).
- ·The top 10 names in the book — of 17 recorded positions
- ·Watchlist + alerts for Bain Capital Life Sciences's activity
Portfolio
17 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Freenome | Decision/Risk Analysis | ▮ | ▮ | ▮ |
| Imperative Care | Surgical Devices | ▮ | ▮ | ▮ |
| HeartFlow (NAS: HTFL) | Decision/Risk Analysis | ▮ | ▮ | ▮ |
+ 14 more companies · all 17, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Funds
4 recorded- Bain Capital Life Sciences Fund IV, L.P.2024—
- Bain Capital Life Sciences Fund III, L.P.2021—
- Bain Capital Life Sciences Fund II, L.P.2019—
- Bain Capital Life Sciences Fund, L.P.2016—
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Bain Capital Life Sciences
- What companies does Bain Capital Life Sciences invest in?
- Bain Capital Life Sciences has 17 recorded portfolio companies, including Freenome, Imperative Care, HeartFlow (NAS: HTFL).
- What is Bain Capital Life Sciences's AUM?
- Bain Capital Life Sciences manages approximately $4.6B in assets.